Art Glasgow
Art Glasgow is chief information officer and vice president for Duke Medicine.
He is responsible for leading technology strategy, innovation, initiatives, and operations across Duke Medicine, which comprises the Duke University Health System, the Duke School of Medicine, Duke School of Nursing, and the Duke faculty practice plan (Private Diagnostic Clinic). In addition, he works in collaboration with Duke-NUS Graduate Medical School in Singapore and Duke Medicine’s other global partners to develop an IT strategy to meet mutual goals.
Before joining Duke, Glasgow served as chief technology officer for Ingenix, Inc., a $2.5 billion health informatics and information technology subsidiary of UnitedHealth Group. In that role, he directed a product and technology team of over 500 products and 1,500 personnel in supporting customers in the provider, commercial payer, government, and life sciences markets. Previously, he managed P&L lines of business in the commercial payer, provider, and health information networks business units within Ingenix.
Prior to joining Ingenix, Glasgow was a vice president with Misys Healthcare (now Allscripts). His various roles at Misys/Allscripts included responsibility for product management for clinical and administrative health care systems, P&L responsibility for the revenue cycle lines of business, and general manager for the Payerpath subsidiary. Glasgow joined Misys following executive roles with several innovative early-stage and start-up IT ventures.
Glasgow graduated, with merit, from the United States Naval Academy with a BS degree and attended graduate studies at Georgetown University. He is a veteran of the United States Marine Corps.
Section Navigation
